Guideline Summary NGC-10120Guideline TitleKnee & leg (acute & chronic).Bibliographic Source(s)Work Loss Data Institute. Knee & leg (acute & chronic). Encinitas (C A): Work Loss Data Institute; 2013 Nov 29. Various p.Guideline StatusThis is the current release of the guideline.This guideline updates a previous version: Work Loss Data Institute. Knee & leg (acute & chronic). Encinitas (C A): Work Loss Data Institute; 2011. Various p.FDA Warning/Regulatory AlertNote from the National Guideline Clearinghouse: This guideline references a drug(s) for which important revised regulatory and/or warning information has been released.July 9, 2015 - Non-aspirin Nonsteroidal Anti-inflammatory Drugs (NSAIDS) : The U.S. Food and Drug Administration (FDA) is strengthening an existing label warningthat non-aspirin nonsteroidal anti-inflammatory drugs (NSAIDs) increase the chance of a heart attack or stroke. Based on FDAs comprehensive review of new safetyinformation, FDA is requiring updates to the drug labels of all prescription NSAIDs. As is the case with current prescription NSAID labels, the Drug Facts labels of overthe-counter (OTC ) non-aspirin NSAIDs already contain information on heart attack and stroke risk. FDA will also request updates to the OTC non-aspirin NSAID DrugFacts labels.ScopeDisease/Condition(s)Work-related knee and leg disordersGuideline CategoryDiagnosisEvaluationManagementTreatmentClinical SpecialtyFamily PracticeInternal MedicineOrth ...
To Order an Original Plagiarism Free Paper on the Same Topic Click Here
Other samples, services and questions:
When you use PaperHelp, you save one valuable — TIME
You can spend it for more important things than paper writing.
